EMAIL THIS PAGE TO A FRIEND

Arthritis research & therapy

Modulation of interleukin-1β-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts.


PMID 21835002

Abstract

Innate defence regulator (IDR) peptides are synthetic cationic peptides, variants of naturally occurring innate immune effector molecules known as host defence peptides. IDR peptides were recently demonstrated to limit infection-associated inflammation selectively without compromising host innate immune functions. This study examined the impact of a 12-amino acid IDR peptide, IDR-1002, in pro-inflammatory cytokine interleukin (IL)-1β-induced responses in synovial fibroblasts, a critical cell type in the pathogenesis of inflammatory arthritis. Human fibroblast-like synoviocytes (FLS) were stimulated with IL-1β in the presence and absence of IDR-1002. Production of enzyme matrix metalloproteinase-3 (MMP-3) and IL-1-receptor antagonist (IL-1RA) was monitored by enzyme-linked immunosorbent assay (ELISA), and various chemokines were evaluated by using multiplex cytometric bead array. Transcriptional responses were analyzed by quantitative real-time PCR. The impact on IL-1β-induced proteome was investigated by quantitative proteomics by using isobaric tags. IL-1β-induced pathways altered by IDR-1002 implicated by the proteomics analyses were further investigated by using various immunochemical assays. Cellular uptake of the peptide was monitored by using a biotinylated IDR-1002 peptide followed by microscopy probing with streptavidin-Alexa Fluor. This study demonstrated that IDR-1002 suppressed the production of IL-1β-induced MMP-3 and monocyte chemotactic protein-1 (MCP-1); in contrast, IDR-1002 enhanced the production of IL-1RA, without neutralizing all chemokine responses. IDR-1002 altered the IL-1β-induced proteome primarily by altering the expression of members of nuclear factor kappa-B (NF-κB) and c-Jun N-terminal kinase (JNK) pathways. The proteomics data also suggested that IDR-1002 was altering the transcription factor HNF-4α-mediated responses, known to be critical in metabolic regulation. With various immunochemical assays, it was further demonstrated that IL-1β-induced NF-κB, JNK, and p38 mitogen-activated protein kinase (MAPK) activations were significantly suppressed by IDR-1002. This study demonstrates the ability of an innate immune-modulatory IDR-peptide to influence the IL-1β-induced regulatory pathways and selectively to suppress inflammatory responses in synovial fibroblasts. The results of this study provide a rationale for examining the use of IDR-peptides as potential therapeutic candidates for chronic inflammatory diseases such as inflammatory arthritis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

05470
Bovine serum albumin, lyophilized powder, crystallized, ≥98.0% (GE)
A4503
Bovine Serum Albumin, cold ethanol fraction, pH 5.2, ≥96%
A7888
Bovine Serum Albumin, heat shock fraction, suitable for RIA, pH 5.2, ≥96%
A3294
Bovine Serum Albumin, heat shock fraction, protease free, pH 7, ≥98%
A6003
Bovine Serum Albumin, lyophilized powder, essentially fatty acid free, ≥96% (agarose gel electrophoresis)
A3059
Bovine Serum Albumin, heat shock fraction, protease free, essentially globulin free, pH 7, ≥98%
A9418
Bovine Serum Albumin, lyophilized powder, BioReagent, suitable for cell culture, ≥96% (agarose gel electrophoresis)
A0281
Bovine Serum Albumin, lyophilized powder, essentially fatty acid free and essentially globulin free, ≥99% (agarose gel electrophoresis)
A7638
Bovine Serum Albumin, lyophilized powder, essentially globulin free, ≥99% (agarose gel electrophoresis)
A8022
Bovine Serum Albumin, heat shock fraction, pH 5.2, ≥96%
A3912
Bovine Serum Albumin, heat shock fraction, pH 5.2, ≥96%
A3803
Bovine Serum Albumin, heat shock fraction, lyophilized powder, essentially fatty acid free, ≥98% (agarose gel electrophoresis)
B4287
Bovine Serum Albumin, heat shock fraction, protease free, suitable for hybridization, pH 7, ≥98%
A8806
Bovine Serum Albumin, fatty acid free, low endotoxin, lyophilized powder, BioReagent, suitable for cell culture, ≥96% (agarose gel electrophoresis)
A4378
Bovine Serum Albumin, lyophilized powder, 1× crystallized, ≥97% (agarose gel electrophoresis)
A7511
Bovine Serum Albumin, lyophilized powder, essentially fatty acid free, ≥97% (agarose gel electrophoresis), 1X Crystallized
A4919
Bovine Serum Albumin, heat shock fraction, protease free, low endotoxin, suitable for cell culture, pH 7, ≥98%
A2058
Bovine Serum Albumin, lyophilized powder, essentially IgG-free, low endotoxin, BioReagent, suitable for cell culture
A3311
Bovine Serum Albumin, powder, BioXtra
A1933
Bovine Serum Albumin, chromatographically purified, New Zealand origin, low endotoxin, suitable for cell culture, pH 7, ≥98%
A4161
Bovine Serum Albumin, lyophilized powder, essentially globulin free, BioReagent, suitable for cell culture
A9430
Bovine Serum Albumin, heat shock fraction, low endotoxin, pH 7, ≥98%
A2934
Bovine Serum Albumin, lyophilized powder, essentially globulin free, low endotoxin, ≥98% (agarose gel electrophoresis)
B6917
Bovine Serum Albumin, lyophilized powder, suitable for (for molecular biology), Non-acetylated
A3156
Bovine Serum Albumin, lyophilized powder, γ-irradiated, Globulin Free, BioXtra, suitable for cell culture
A9306
Bovine Serum Albumin, lyophilized powder, low endotoxin, ≥95% (agarose gel electrophoresis)
A9543
Bovine Serum Albumin, heat shock fraction, low endotoxin, pH 7, ≥98%
A3675
Bovine Serum Albumin, lyophilized powder, low endotoxin, ≥98% (agarose gel electrophoresis)
A9056
Bovine Serum Albumin, lyophilized powder, Microbiologically tested, ≥96% (agarose gel electrophoresis)
A9085
Bovine Serum Albumin, lyophilized powder, essentially IgG free, ≥96% (agarose gel electrophoresis)